LTP ltr pharma limited

Ann: Commercial Update and Regulatory Progress, page-354

  1. 8 Posts.
    lightbulb Created with Sketch. 3
    The issue with the patent is novelty. Is it sufficiently novel as a method to suspend a drug in a liquid using a particular type of chemistry.

    I couldn't patent suspending panadol in honey - so it's all about whatever the chemistry is around suspension. If that is well trodden there is a risk that it can't be patented - which happens not infrequently. If there is a back and forward with the patent office I wouldn't assume its administrative.

    Hopefully for the sake of the small amount of money I am into this for they can get an effective patent. The issue will be that given the drug is a generic, the moat is delivery only.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
29.5¢
Change
0.015(5.36%)
Mkt cap ! $33.02M
Open High Low Value Volume
28.5¢ 31.0¢ 28.5¢ $112.8K 382.8K

Buyers (Bids)

No. Vol. Price($)
2 19244 29.5¢
 

Sellers (Offers)

Price($) Vol. No.
31.0¢ 64264 2
View Market Depth
Last trade - 16.10pm 20/06/2025 (20 minute delay) ?
LTP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.